Greater early postprandial suppression of endogenous glucose production is achieved with fast-acting insulin aspart compared to insulin aspart

被引：0
|
作者：
Pieber, T. R. [1 ]
Basu, A. [2 ]
Hansen, A. K. [3 ]
Sach-Friedl, S. [1 ]
Thomsen, K. M. D. [3 ]
Basu, R. [2 ]
Haahr, H. [3 ]
机构：
[1] Med Univ Graz, Graz, Austria
[2] Mayo Clin, Rochester, MN USA
[3] Novo Nordisk, Soborg, Denmark
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
690
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [41] Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart
    Heise, T.
    Hoevelmann, U.
    Brondsted, L.
    Adrian, C. L.
    Nosek, L.
    Haahr, H.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (07): : 682 - 688
  • [42] Efficacy and safety of fast-acting insulin aspart in adults with type 2 diabetes with different insulin requirements
    Sesti, G.
    Lane, W.
    Ekelund, M.
    Thorisdottir, O.
    Jodar, E.
    Oviedo, A.
    Rathor, N.
    Senior, P.
    Franek, E.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S330 - S330
  • [43] FAST-ACTING INSULIN ASPART: A REVIEW OF ITS PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES AND THE CLINICAL CONSEQUENCES
    Haahr, Hanne
    Heise, Tim
    [J]. DIABETES MELLITUS, 2020, 23 (02): : 140 - 160
  • [44] The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes
    Biester, Torben
    von Dem Berge, Thekla
    Bendtsen, Line Quist
    Bendtsen, Mette Dahl
    Rathor, Naveen
    Danne, Thomas
    Haahr, Hanne
    [J]. PEDIATRIC DIABETES, 2020, 21 (05) : 781 - 790
  • [45] Higher early insulin exposure and greater early glucose-lowering effect with faster-acting insulin aspart vs insulin aspart in elderly and younger adults with type 1 diabetes
    Hovelmann, U.
    Zijlstra, E.
    Stender-Petersen, K.
    Jacobsen, J. B.
    Heise, T.
    Haahr, H.
    [J]. DIABETOLOGIA, 2015, 58 : S450 - S450
  • [46] Postprandial glucose control using the Medtronic Advanced Hybrid Closed Loop System: faster-acting insulin aspart vs insulin aspart
    Lee, M. H.
    Vogrin, S.
    Paldus, B.
    Morrison, D.
    Zaharieva, D.
    Lu, J.
    Jones, H.
    Netzer, E.
    Sims, C.
    MacIsaac, R. J.
    Grosman, B.
    Roy, A.
    Kurtz, N.
    Jenkins, A.
    O'Neal, D. N.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S328 - S328
  • [47] Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences
    Hanne Haahr
    Tim Heise
    [J]. Clinical Pharmacokinetics, 2020, 59 : 155 - 172
  • [48] Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences
    Haahr, Hanne
    Heise, Tim
    [J]. CLINICAL PHARMACOKINETICS, 2020, 59 (02) : 155 - 172
  • [49] Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
    Hoevelmann, Ulrike
    Heise, Tim
    Nosek, Leszek
    Sassenfeld, Bettina
    Thomsen, Karen Margrete Due
    Haahr, Hanne
    [J]. CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 503 - 509
  • [50] Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
    Ulrike Hövelmann
    Tim Heise
    Leszek Nosek
    Bettina Sassenfeld
    Karen Margrete Due Thomsen
    Hanne Haahr
    [J]. Clinical Drug Investigation, 2017, 37 : 503 - 509
12345